Eli Lilly’s Zepbound eases obstructive sleep apnea in trials
Eli Lilly reported Wednesday that the GLP-1 drug cut breathing interruptions in obese or overweight patients experiencing the condition.
Eli Lilly reported Wednesday that the GLP-1 drug cut breathing interruptions in obese or overweight patients experiencing the condition.
Show Pediheart: Pediatric Cardiology Today, Ep Pediheart Podcast #295: Right Atrial Thrombus Post Gore Cardioform ASD Closure – Reason For Concern? – May 2, 2024
A dry desert wind blew into the mouth of Bizmoune Cave on the flank of a limestone mountain in western Morocco. Last November, two students…
Safely integrating AI into the clinical workflow could help address some of the limitations of human cognition when it comes to diagnosing medical problems.
AbstractAims. Over time, cardiovascular disease (CVD) deaths increasingly exceed those from malignancy among cancer survivors. However, the association of
Engaging people with bipolar disorder and translating their experiences into scientific research will help move from hope to real improvements in treatment.
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by…
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by…
The Edwin Bierman Award Lecture is presented in honor of the memory of Edwin L. Bierman, MD, an exemplary scientist, mentor, and leader in the…
Vinay K. Bhal and Mamas Mamas discuss the distinct precursors, epidemiology, and care of valvular heart disease in India.
AbstractBackground and Aims. Patients undergoing revascularization for lower extremity arterial disease (LEAD) may face a higher risk of mortality than tho